isolated from serum samples of 170 patients with known HCV infection. The nested reverse transcriptase reaction was used to synthesize the complementary DNA (cDNA) and the fragment
Efavirenz (Efv), which belongs to BCS class II. Efv is non neucleotide reverse transcriptase inhibitor (NNRTI) for first line antiretroviral treatment type 1 with long half life
Scpa-ETFB, the signature sequences of the ETF superfamily were identified. Using reverse transcriptase polymerase chain reaction, we detected the messenger RNA transcript of Scpa-ETFB in high levels
subjected to RNA extraction and the other part was not, before performing reverse transcriptase (RT)-PCR. The assay succeeded to type BVDV with and without extraction RNA, as well
high proliferative potential, the migratory and homing (?invasiveness?) capabilities, telomere length, telomerase and reverse transcriptase activity and gene expression are only a few of biological characteristic or…
aqueous solubility 4 μg/mL and oral bioavailability 40-45%, having non-nucleoside reverse transcriptase inhibitor (NNRTI) antiretroviral activity. The aim of the present study was to develop a Self
Nevirapine is a non–nucleoside Reverse Transcriptase inhibitor, antiviral agent. A simple, selective, and sensitive high performance liquid chromatography method for the determination of Nevirapine in human plasma was…
Lake in Jeddah city. Samples were screened for the presence of rotavirus by reverse transcriptase-polymerase chain reaction (RT-PCR) technique. A total of 65 (65%) samples were found
their total cellular RNA and proteins were isolated. Quantitative real-time reverse transcriptase-polymerase chain reaction and Western blot were performed to determine the mRNA and protein levels of these
product acceptance from a Phase I clinical trial of a candidate non-nucleoside reverse transcriptase inhibitor (NNRTI) vaginal microbicide product (UC781). The product was evaluated in the context
treatment basis in HIV-1 infected children is a combination of 2 nucleoside reverse transcriptase inhibitors and 1 protease inhibitor or 1 non NRTI. However, after few months or years
developed Fanconi syndrome, hypophosphatemic osteomalacia and bone fractures while on tenofovir, a nucleotide reverse transcriptase inhibitor, commonly used as part of HIV treatment. All patients presented with bone…
combination with compounds of four different classes of antiretroviral drugs (entry inhibitors, reverse transcriptase inhibitors, integrase inhibitors and protease inhibitors)in cell-cell HIV transmission routes and…
disproxil fumarate belongs to class of anti-retroviral drugs known as nucleotide analogue reverse transcriptase inhibitors. The main objective of the present study is to formulate and evaluate an immediate
disease of proximal renal tubule with inherited or acquired etiology. Nucleotide reverse transcriptase inhibitors (NtRTIs) are well known causes of this entity. Tenofovir is one of the safest drug
analysis either by conventional Karyotyping, FISH (fluorescence in situ hybridization) and RT-PCR (Reverse transcriptase polymerase chain reaction). The antigen expressions by immunophenotype in acute myeloid and…
reverse transcriptase telomerase is one of the hallmarks of cancer and an excellent candidate for targeting cancer. Imetelstat is a potent inhibitor of telomerase with demonstrated anti-tumor eff ects
analyzed using osteogenesis cDNA gene array. The selected genes were verified using reverse transcriptase (RT)-PCR analysis. Human periosteal cells differentiated along an osteogenic lineage after treatment
therapy is mainly focusing on blocking the function of viral proteins, such as Reverse Transcriptase, Protease, or Integrase, to treat AIDS patients. Although the intended purpose of antiviral drugs
this interaction may be instrumental in the switching of the RdRp from a transcriptase to replicase mode. In this work we provide the fi rst evidence that this interaction
investigated, including 217 nucleos(t)ide analog-experienced patients. HBV genotypes/subgenotypes and reverse transcriptase (RT) mutations were determined by direct sequencing. Th e stage of fi brosis and degree
Anti-HIV activity was assessed based on inhibition of р24 protein concentration and reverse transcriptase (RT) activity. It was shown that the drug administered once 24 hours prior to mononuclear
clinical strains. The SMART (switching mechanism at 5ꞌ end of RNA template of reverse transcriptase) technique was used to construct a full-length cDNA library of an HCMV clinical strain
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.